NCT06040749

Virtual Sport for Adults ≥ 50 Years With Spinal Cord Injury

Peer-facilitated Virtual Sport for Adults ≥ 50 Years With Spinal Cord Injury
University Health Network, Toronto·ClinicalTrials.gov·otherRecruiting
View on ClinicalTrials.gov
Study focus
Disease/Condition
Spinal Cord Injury
Drug/Device/Intervention
Virtual group-based handcycling
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
University Health Network, Toronto
Location
Toronto, Canada
Timeline & enrollment
Phase
N/A
Start date
May 05, 2023
End date
Aug 01, 2024
Enrollment
20 participants
Primary outcome

Spinal Cord Independence Measure,Positive Affect and Well-Being Scale of the Quality of Life in Neurological Disorders Measure (PAWB-Neuro-QoL),Multidimensional Scale of Perceived Social Support,Moorong Self-Efficacy Scale,Spinal Cord Injury Exercise Self-Efficacy Scale,6 Minute Push Test,Semi-structured Interview

Summary

Sport is a physical activity that has many physical, psychological and social benefits for
 those with spinal cord injury (SCI). However, most sport research involves people with SCI
 who are 50 years old. This is a problem because many people are 50 years old when first
 injured. Moreover, people with a SCI are now living longer lives, meaning they also
 experience more health challenges. Unfortunately, there is limited research studying the
 impact of sport for adults with SCI aged ≥50 years old.

ICD-10 classifications
Sequelae of injury of spinal cordOther injury of lumbar spinal cordInjury of spinal cord, level unspecifiedOther and unspecified injuries of thoracic spinal cordOther and unspecified injuries of cervical spinal cord
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06040749
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06040749 through Pure Global AI's free database. This phase not specified trial is sponsored by University Health Network, Toronto and is currently Recruiting. The study focuses on Spinal Cord Injury. Target enrollment is 20 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.